Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Young Embryologist Network Conference 2025

Are you an early career researcher in developmental or stem cell biology? Don’t miss the 17th Young Embryologist Network (YEN) Conference—an annual, student- and postdoc-led [...]

Go to Top